Systemic Sclerosis Flashcards

1
Q

What is systemic sclerosis?

A

Autoimmune inflammatory progressive multisystem connective tissue disease. Charcterised by small vessel vasculopathy and abnormal collagen deposition leading to fibrosis of the skin and internal organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Subtypes of systemic sclerosis

A
  • Limited cutaneous systemic sclerosis (CREST)- skin involvement limited distal to knees and elbows. Internal organs still affected
  • Diffuse cutaneous systemic sclerosis- diffuse skin involvement past the knees and elbows
  • Overlap syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of systemic sclerosis

A

1 in 10,000
4:1 female: male
RFx- silicone breast implants, previous chemotherapy (esp bleomycin), silica dust, exposure to gadolinium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Extra-cutaneous conditions associated with systemic sclerosis

A
  • CKD
  • Pulmonary fibrosis
  • Pulmonary hypertension
  • Myocardial ischaemia
  • OSA
  • Arrhythmias
  • CVA
  • Chronic pain from peripheral neuropathies and skin lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of systemic sclerosis

A

An unknown trigger in a susceptible individual leads to…
- Endothelial cells proliferate and cause vasoconstriction leading to localised tissue necrosis and large vessel disease (pulm HTN, renal crisis)
- Fibroblasts produce aberrant collagen and lead to tissue fibrosis and loss of elasticity
- Inflammatory mediators ET1, PDGF released and anti-centromere antibodies produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CFx of systemic sclerosis

A

Cutaneous:
- sclerodactyly
- Calcinosis
- Widespread telangiectasia
- Puffy hands
- Raynaud’s

Organs-
- PAH
- CKD
- Reflux

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacological treatment for systemic sclerosis

A
  1. Immunomodulation: steroids, rituximab, mycophenolate, tocilizumab
  2. ILD antifibrotics: nintedanib
  3. Vasodilators: Ca channel blockers, phosphodiesterase inhibitors, prostacyclin analogues
  4. General cardiac disease modulators: ACEi, diuretics
  5. General GI disease modulators: PPI, antacid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anaesthetic Considerations for Systemic Sclerosis

A

Airway
- Can have limited mouth opening and neck movement may need ATI
- OSA common

Respiratory
- Interstitial lung disease and fibrosis, restrictive defects
- Difficult ventilation
- Weakness may need post-op ventilation

Cardiovascular
- Heart blocks common
- Risk of MI
- Risk of rt heart failure
- Can have pericarditis

CNS
- Seizures and headaches are common
- Often chronic pain and peripheral neuropathies

MSK
- Difficult IV access
- Difficult pulse oximetry
- Muscle weakness common in late disease
- Pressure sore
- Raynauds- potentially severe pain on IV propofol

GI
- High aspiration risk
- Malabsorption and malnutrition common

Renal
- High risk of systemic sclerosis renal injury
- AKI

Haematological
- High risk of VTE
- Some overlap with anti-phospholipid syndrome
- Anaemia of chronic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly